InvestorsHub Logo
Followers 46
Posts 2450
Boards Moderated 0
Alias Born 04/17/2019

Re: T Stark post# 90779

Saturday, 07/04/2020 5:48:01 PM

Saturday, July 04, 2020 5:48:01 PM

Post# of 233477
Lenzilumab is yet another study thats cherry picking patients.

Any condition that, in the opinion of the investigator, is likely to interfere with the safety and efficacy of the study treatment





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News